Diarmuid Moran

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

Kohei Shitara, Florian Lordick, Yung‐Jue Bang et al. · The Lancet · 2023 · 609 citations

Oncology, Esophageal Cancer, Gastrointestinal Oncology +9

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Manish A. Shah, Kohei Shitara, Jaffer A. Ajani et al. · Nature Medicine · 2023 · 450 citations · Full text

Esophageal Cancer, Glow Trial, Cancer Management +16

Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes

Kimberly R. Doherty, Robert Wappel, Dominique R. Talbert et al. · Toxicology and Applied Pharmacology · 2013 · 166 citations

Cardiomyopathy, Medicine, Cardiovascular Pharmacology +8

Effect of seminal plasma dilution or removal on spermatozoal motion characteristics of cooled stallion semen

D.J. Jasko, Diarmuid Moran, M.E. Farlin et al. · Theriogenology · 1991 · 118 citations

Spermatogenesis, Infertility, Andrology +11

Determination of temperature and cooling rate which induce cold shock in stallion spermatozoa

Diarmuid Moran, D.J. Jasko, E.L. Squires et al. · Theriogenology · 1992 · 101 citations

Animal Physiology, Infertility, Animal Reproduction +11